Smithtown Primary Medical Care, P.c. - Medicare Primary Care in Smithtown, NY

Smithtown Primary Medical Care, P.c. is a medicare enrolled primary clinic (Family Medicine) in Smithtown, New York. The current practice location for Smithtown Primary Medical Care, P.c. is 100 Maple Ave, Smithtown, New York. For appointments, you can reach them via phone at (631) 265-7671. The mailing address for Smithtown Primary Medical Care, P.c. is 100 Maple Ave, Smithtown, New York and phone number is (631) 265-7671.

Smithtown Primary Medical Care, P.c. is licensed to practice in New York (license number 120634-1). The clinic also participates in the medicare program and its NPI number is 1326243536. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (631) 265-7671.

Contact Information

Smithtown Primary Medical Care, P.c.
100 Maple Ave
Smithtown
NY 11787-3502
(631) 265-7671
(631) 265-7692

Primary Care Clinic Profile

Full NameSmithtown Primary Medical Care, P.c.
SpecialityFamily Medicine
Location100 Maple Ave, Smithtown, New York
Authorized Official Name and PositionRonald Roth (PRESIDENT)
Authorized Official Contact6312657671
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Smithtown Primary Medical Care, P.c.
100 Maple Ave
Smithtown
NY 11787-3502

Ph: (631) 265-7671
Smithtown Primary Medical Care, P.c.
100 Maple Ave
Smithtown
NY 11787-3502

Ph: (631) 265-7671

NPI Details:

NPI Number1326243536
Provider Enumeration Date06/18/2007
Last Update Date09/29/2011

Medicare PECOS Information:

Medicare PECOS PAC ID2163609579
Medicare Enrollment IDO20110613000565

News Archive

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

FDA accepts Gilead's Truvada sNDA and grants Priority Review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.

Researchers identify novel molecular target for Yersinia

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.

Fruit fly faeces provides answers to pregnant women's bloating and constipation

Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Smithtown Primary Medical Care, P.c. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1326243536NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 120634-1 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Smithtown Primary Medical Care, P.c. acts as a billing entity for following providers:
Provider NameRonald Roth
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1891870234
PECOS PAC ID: 1153519053
Enrollment ID: I20110613000398

News Archive

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

FDA accepts Gilead's Truvada sNDA and grants Priority Review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.

Researchers identify novel molecular target for Yersinia

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.

Fruit fly faeces provides answers to pregnant women's bloating and constipation

Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).

Read more Medical News

› Verified 9 days ago

Provider NamePriscilla Lamura
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124749130
PECOS PAC ID: 2961875455
Enrollment ID: I20230303000708

News Archive

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

FDA accepts Gilead's Truvada sNDA and grants Priority Review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.

Researchers identify novel molecular target for Yersinia

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.

Fruit fly faeces provides answers to pregnant women's bloating and constipation

Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).

Read more Medical News

› Verified 9 days ago

Provider NameBarbara Mazzola
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1629106695
PECOS PAC ID: 4486977204
Enrollment ID: I20240219003693

News Archive

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

FDA accepts Gilead's Truvada sNDA and grants Priority Review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.

Researchers identify novel molecular target for Yersinia

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.

Fruit fly faeces provides answers to pregnant women's bloating and constipation

Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).

Read more Medical News

› Verified 9 days ago

News Archive

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today's news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

FDA accepts Gilead's Truvada sNDA and grants Priority Review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.

Researchers identify novel molecular target for Yersinia

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.

Fruit fly faeces provides answers to pregnant women's bloating and constipation

Clues about how the human gut helps regulate our appetite have come from a most unusual source - fruit fly faeces. Scientists at the University of Cambridge are using the fruit fly to help understand aspects of human metabolism, including why pregnant women suffer from bloating and constipation, and even the link between a low calorie diet and longevity.

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver's blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers. The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual meeting of the American Society of Clinical Oncology (ASCO).

Read more News

› Verified 9 days ago


Family Medicine in Smithtown, NY

Raul R. Trinchet, M.d., P.c.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 285 Middle Country Road, Suite Ll-2, Smithtown, NY 11787
Phone: 631-979-4541    Fax: 631-979-4546
Pilip Medical Treatments P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 732 Smithtown Byp Ste 305, Smithtown, NY 11787
Phone: 631-656-9040    Fax: 631-648-9661
Omni Medical 360 Pllc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 100 Maple Ave, Smithtown, NY 11787
Phone: 631-813-7788    
Optimum Care Family Medicine, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 321 E Main St Ste 1, Smithtown, NY 11787
Phone: 631-265-4606    Fax: 631-265-4675
Long Island Gastroenterology And Liver Disease P.c.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 48 Route 25a Ste 307, Smithtown, NY 11787
Phone: 631-265-0062    Fax: 631-265-0590
Infectious Disease Medical Practice Of Ny Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 48 Route 25a, Suite 308, Smithtown, NY 11787
Phone: 631-864-6111    Fax: 631-864-5004
Vp Medical, Pc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 20 Gilbert Ave, Smithtown, NY 11787
Phone: 347-987-1168    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.